Pathological Tumor and Lymph Node Responses After Neoadjuvant Immunochemotherapy in Initially-unresectable NSCLC

Clinical trial NCT05637580 · COMPLETED

Trial details

NCT number: NCT05637580
Sponsor: Guangdong Provincial People's Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Non Small Cell Lung Cancer Immunotherapy Chemotherapy Tumour, Residual

Start date: 2019-05-20
Primary completion: 2022-07-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.